Automated insulin therapy for kids 2-6 with type 1 diabetes
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This study tests a semi-automated insulin pump system in very young children (ages 2–6) with type 1 diabetes. It aims to see if the device improves quality of life and blood sugar control.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child is between 2 and 6 years old.
- Your child has type 1 diabetes and uses insulin.
- Your child is about to start using a semi-closed loop insulin pump system.
- You or another parent/guardian can attend training on how to use a continuous glucose monitor.
- You live in France or are covered by French social security.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies how the Medtronic 780G “closed-loop” insulin system works for young people with type 1 diabetes. It may help by improving how automatically insulin is delivered, depending on your body’s needs.
This study tests whether starting an automated insulin delivery (AID) system soon after a type 1 diabetes diagnosis helps improve blood sugar control and reduces future health problems. The AID system combines a pump and continuous glucose monitor to automatically adjust insulin.
This study tests a new automated insulin delivery system to help people with type 1 diabetes better manage their blood sugar. It aims to see if the system improves glucose control safely.
This study tests a system that measures blood sugar and automatically adjusts insulin delivery. It is for adults with type 1 diabetes who use insulin injections or a pump.
This study tests if a simpler way of calculating meal insulin works as well as counting carbohydrates for teens using hybrid closed loop (automated insulin) systems. If you're a teen with type 1 diabetes and use an automated pump, this trial could help find an easier mealtime routine.
This study tests an early use of an automated insulin delivery system for people recently diagnosed with type 1 diabetes. The goal is to see if starting this technology soon after diagnosis helps with blood sugar control and quality of life.
Hear when a new Type 1 diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.